Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS)
CNY 22.57
(-0.92%)
CNY 22.57
(-0.92%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 8.99 Billion CNY | -15.96% |
| 2022 | 10.7 Billion CNY | 19.24% |
| 2021 | 8.97 Billion CNY | 151.23% |
| 2020 | 3.57 Billion CNY | 888.41% |
| 2019 | 361.51 Million CNY | 7.07% |
| 2018 | 337.64 Million CNY | 30.21% |
| 2017 | 259.31 Million CNY | 7.6% |
| 2016 | 240.99 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 8.75 Billion CNY | -2.63% |
| 2024 Q2 | 8.44 Billion CNY | -3.61% |
| 2024 Q3 | 8.23 Billion CNY | -2.47% |
| 2023 Q1 | 10.54 Billion CNY | -1.51% |
| 2023 FY | 8.99 Billion CNY | -15.96% |
| 2023 Q4 | 8.99 Billion CNY | -1.9% |
| 2023 Q3 | 9.16 Billion CNY | -5.58% |
| 2023 Q2 | 9.71 Billion CNY | -7.88% |
| 2022 Q2 | 11.74 Billion CNY | 0.06% |
| 2022 Q1 | 11.73 Billion CNY | 30.78% |
| 2022 FY | 10.7 Billion CNY | 19.24% |
| 2022 Q4 | 10.7 Billion CNY | -3.3% |
| 2022 Q3 | 11.06 Billion CNY | -5.77% |
| 2021 Q1 | 4.95 Billion CNY | 38.8% |
| 2021 FY | 8.97 Billion CNY | 151.23% |
| 2021 Q2 | 7.75 Billion CNY | 56.36% |
| 2021 Q3 | 7.26 Billion CNY | -6.33% |
| 2021 Q4 | 8.97 Billion CNY | 23.58% |
| 2020 Q4 | 3.57 Billion CNY | 101.43% |
| 2020 FY | 3.57 Billion CNY | 888.41% |
| 2020 Q3 | 1.77 Billion CNY | 9.25% |
| 2020 Q2 | 1.62 Billion CNY | 46.82% |
| 2020 Q1 | 1.1 Billion CNY | 205.92% |
| 2019 Q3 | 315.36 Million CNY | -0.9% |
| 2019 Q4 | 361.51 Million CNY | 14.63% |
| 2019 Q2 | 318.23 Million CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 FY | 361.51 Million CNY | 7.07% |
| 2018 FY | 337.64 Million CNY | 30.21% |
| 2018 Q4 | 337.64 Million CNY | 0.0% |
| 2017 FY | 259.31 Million CNY | 7.6% |
| 2016 FY | 240.99 Million CNY | 0.0% |